ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 267

Risk Of Falls Increases With Additional Symptomatic Osteoarthritic Joints: The Johnston County Osteoarthritis Project

Adam Dore1, Yvonne M. Golightly2, Vicki Mercer3, Jordan B. Renner4, Xiaoyan A. Shi5, Joanne M. Jordan6 and Amanda E. Nelson7, 1Rheumatology, Allergy and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Gillings School of Global Public Health, Dept of Epidemiology, Thurston Arthritis Research Center, Injury Prevention Research Center, University of North Carolina Dept of Epidemiology, Chapel Hill, NC, 3Division of Physical Therapy, Dept of Allied Health Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, 4University of North Carolina Department of Radiology, Chapel Hill, NC, 5SAS Institute, Inc, Cary, NC, 6Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 7University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Fall Risk and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Risk Factors for and Sequelae of Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: Falls, a growing problem among older adults, often lead to hospitalizations, surgeries, and death. Knee and hip osteoarthritis (OA) are known risk factors for falls, but whether they together additionally contribute to falls risk is unknown. This study utilizes a cohort of African American and Caucasian men and women with and without OA to examine the influence of body OA burden on risk for future falls. 

Methods: A longitudinal analysis was performed using data from 2 time points of the Johnston County OA Project. The outcome of interest was falls at follow up (~5 years after initial visit), based on the response to the question “In the last 12 months, have you had any falls of any type?” Baseline risk factors included age, sex, race, body mass index, and prior falls, with a focus on symptomatic OA of the hip and knee (Model 1). Symptomatic OA was defined as patient reported symptoms (pain, aching, or stiffness on most days) and radiographic evidence of OA (Kellgren Lawrence grade ≥ 2 or joint replacement secondary to OA in the tibiofemoral or hip joint) in the same joint. Additional potential contributing factors were 6 comorbid conditions, alcohol and medication use (sleep aids, narcotics, vitamin D, and bisphosphonates), and low back symptoms (Model 2). Logistic regression analyses were used to determine associations (adjusted odds ratios [aOR]) between baseline covariates and falls at follow-up in both Models 1 and 2.

Results: Participants (n=1,619) had a mean age of 62 years (SD 9.03); 72% were Caucasian, 35% male, 22% had ≥ 1 fall within 12 months of the baseline time point and 26% had ≥1 fall within 12 months of the follow up visit. Caucasians (aOR 1.37), females, older adults, those who reported a history of lung problems (aOR 1.56) and particularly those who had a fall at baseline (aOR 2.42) had greater odds of a fall at follow-up (Model 1; Table 1). When controlling for baseline characteristics (Model 1), patients who had symptomatic knee or hip OA had increased odds for falling (aOR 1.41 and 1.70, respectively). In Model 2, Caucasians (aOR 1.41), older adults, those who had a previous fall (aOR 2.38), reported a history of depression (aOR 1.02), and symptomatic hip OA (aOR 1.56) had increased odds of falls. However, the association between falls and symptomatic knee OA as well as female sex were no longer significant. The odds of falls increased with an increasing number of knee and/or hip joints with symptomatic OA: the aOR for patients with 1 involved joint was 1.56 (95% CI 1.12, 2.17), for 2 joints was 1.85 (CI 1.28, 2.68), and for 3-4 joints was 1.91 (95% CI 1.01, 3.65).

Conclusion: This study confirms that symptomatic knee and particularly hip OA are important risk factors for falls and reveals that the risk increases with additional symptomatic knee and hip joints. Future interventions aimed at enhancing fall prevention should not ignore the impact of multiple symptomatic OA joints.

Table 1. Characteristics of the Sample (n=1619)

 

Frequency

Model 1

Model 2

Characteristic

Baseline n(%) or mean (range)

OR (95% CI)

OR (95% CI)

Caucasian

1245 (71.6)

1.37 (1.04, 1.81)

1.41 (1.05, 1.88)

Male

484 (34.7)

0.72 (0.55, 0.93)

0.80 (0.61, 1.05)

Mean Age (years)

62 (45-89)

1.03 (1.01, 1.04)

1.03 (1.01, 1.04)

Mean BMI (kg/m2)

30.8 (17.1-65.8)

1.01 (0.99, 1.03)

1.01 (0.99, 1.03)

Falls at baseline

352 (21.8)

2.42 (1.85, 3.17)

2.38 (1.80, 3.14)

Symptomatic Knee OA

321 (20.2)

1.41 (1.05, 1.91)

1.28 (0.92, 1.78)

Symptomatic Hip OA

196 (12.9)

1.70 (1.22, 2.36)

1.56 (1.08, 2.25)

Lung problems1

311 (19.2)

—

1.56 (1.15, 2.10)

Narcotic use2

50 (3.1)

—

1.70 (0.88, 3.29)

CES-D3

6.1 (0-53)

—

1.02 (1.00, 1.03)

Low Back Symptoms4

776 (48.0)

—

1.00 (0.77, 1.29)

1. Includes patient report of chronic bronchitis, emphysema or other chronic lung trouble (dichotomous)

2. Defined as self-reported narcotic use for > 2 weeks (dichotomous)

3. Center for Epidemiologic Studies Depression scale (continuous, 0-60)

4. Answer to: “On most days, do you have pain, aching, or stiffness in your low back?”

 


Disclosure:

A. Dore,
None;

Y. M. Golightly,
None;

V. Mercer,
None;

J. B. Renner,
None;

X. A. Shi,
None;

J. M. Jordan,

Trinity Partners, Inc. ,

5,

Osteoarthritis Research Society International,

6,

Chronic Osteoarthritis Management Initiative of US Bone and Joint Initiative,

6,

Samumed,

5,

Interleukin Genetics, Inc. ,

5,

Algynomics, Inc. ,

1;

A. E. Nelson,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-falls-increases-with-additional-symptomatic-osteoarthritic-joints-the-johnston-county-osteoarthritis-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology